Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 1
2003 1
2005 1
2006 2
2007 2
2008 7
2009 16
2010 10
2011 24
2012 36
2013 43
2014 52
2015 28
2016 37
2017 42
2018 86
2019 194
2020 284
2021 362
2022 328
2023 116
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31570100

1,418 results

Results by year

Filters applied: . Clear all
Page 1
Extended-release naltrexone opioid treatment at jail reentry (XOR).
McDonald RD, Tofighi B, Laska E, Goldfeld K, Bonilla W, Flannery M, Santana-Correa N, Johnson CW, Leibowitz N, Rotrosen J, Gourevitch MN, Lee JD. McDonald RD, et al. Contemp Clin Trials. 2016 Jul;49:57-64. doi: 10.1016/j.cct.2016.05.002. Epub 2016 May 10. Contemp Clin Trials. 2016. PMID: 27178765 Free PMC article. Clinical Trial.
The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O'Grady KE, Lee JD. Chandler RK, et al. Contemp Clin Trials. 2016 May;48:166-72. doi: 10.1016/j.cct.2016.05.003. Epub 2016 May 11. Contemp Clin Trials. 2016. PMID: 27180088 Free PMC article. Clinical Trial.
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.
Murphy SM, Jeng PJ, Poole SA, Jalali A, Vocci FJ, Gordon MS, Woody GE, Polsky D. Murphy SM, et al. Addict Sci Clin Pract. 2020 Apr 22;15(1):15. doi: 10.1186/s13722-020-00188-5. Addict Sci Clin Pract. 2020. PMID: 32321570 Free PMC article. Clinical Trial.
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
Cheng A, Badolato R, Segoshi A, McDonald R, Malone M, Vasudevan K, Badiei B, Sugarman A, Macdonald R, Mangat J, Giftos J, Lee JD, Tofighi B. Cheng A, et al. Addict Sci Clin Pract. 2022 Jan 29;17(1):4. doi: 10.1186/s13722-022-00288-4. Addict Sci Clin Pract. 2022. PMID: 35093164 Free PMC article.
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail.
Gordon MS, Mitchell SG, Blue TR, Vocci FJ, Fishman MJ, Murphy SM, Couvillion K, Maher K, Ryan D, Wenzel K, Danner ML, Jarvis DK. Gordon MS, et al. J Subst Abuse Treat. 2021 Sep;128:108241. doi: 10.1016/j.jsat.2020.108241. Epub 2020 Dec 11. J Subst Abuse Treat. 2021. PMID: 33339633 Free PMC article.
1,418 results